Tim Wright, M.D., is a General Partner at Time BioVentures with a career spanning academia, big pharma, and biotech. He has guided development of twenty marketed drugs and held leadership roles at Pfizer and Novartis.
At firms with a similar stage, sector and check size.



One email when Tim's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckTim Wright, M.D., is a General Partner at Time BioVentures with a career spanning academia, big pharma, and biotech. He has guided development of twenty marketed drugs and held leadership roles at Pfizer and Novartis.
TIME BioVentures has not reported a check size. It invests at seed, series a, series b.
A warm intro from a founder TIME BioVentures backed works best.
Research and Exploratory Development at Pfizer; Deputy Head of Translational Research, Global Head of Translational Medicine, Global Head of Translational Sciences, Global Head of Pharma Development at Novartis Pharmaceuticals; Executive Vice President at CALIBR; Chief R&D officer at Regulus Therapeutics; Associate Professor and Division Chief at University of Pittsburgh School of Medicine; Pfizer; Global Head of Pharma Development at Novartis Pharmaceuticals.
Last updated 2026-10-15. Is this you? Ask for a correction.